Skip to main content
Premium Trial:

Request an Annual Quote

... as Wyeth Expands Existing License to Ingenuity s Pathway Software

NEW YORK, Oct. 25 (GenomeWeb News) - Wyeth Pharmaceuticals has expanded its license for Ingenuity's Pathways Analysis application, Ingenuity said today.


Wyeth will deploy the latest release of the software to its researchers in discovery and development organizations worldwide, Ingenuity said.


Ingenuity Pathways Analysis 3.0 allows scientists to integrate their discoveries into Ingenuity networks for analysis and to create customized pathways for targets, biomarkers, disease areas and processes.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.